previous compound ID: 564 next compound
InChIKey: FDGQSTZJBFJUBT-UHFFFAOYSA-N
SMILES: C1=NC2=C(N1)C(=O)N=CN2

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"E Matthes" "GW Carlile" "SD Macknight" "JW Hanrahan" "J Liao" "B Kus" "D Rotin" "DY Thomas" "J Goepp" "R Robert"

chemical graph of compound 564





CID is 790
synonyms found at PubChem are:
hypoxanthine, 68-94-0, 6-Hydroxypurine, 9H-Purin-6-ol, 6-Oxopurine, Sarkin, Sarcine, Sarkine, Purin-6(1H)-one, Purin-6-ol, Hypoxanthine enol, 6(1H)-Purinone, 7H-Purin-6-ol, 9H-Purin-6(1H)-one, 3H-Purin-6-ol, Purin-6(3H)-one, 6-Hydroxy-1H-purine, Purine-6-ol, 1,7-Dihydro-6H-purin-6-one, 6H-Purin-6-one, 1,7-dihydro-, 1H-Purin-6(9H)-one, 9H-Purin-6-ol (VAN), 1,9-dihydro-6H-purin-6-one, 3,7-dihydropurin-6-one, 6H-Purin-6-one, 1,9-dihydro-, NSC 14665, 1H-Purin-6-ol (9CI), 3H-Purin-6-ol (9CI), UNII-2TN51YD919, 6,7-dihydro-3H-purin-6-one, 146469-94-5, 1,7-Dihydro-6H-purine-6-one, CHEBI:17368, AI3-52242, EINECS 200-697-3, 1,9-dihydropurin-6-one, HX, CHEMBL1427, 9H-Purin-6-ol (9CI), Hypoxanthine (VAN) (8CI), FDGQSTZJBFJUBT-UHFFFAOYSA-N, 2TN51YD919, 146469-95-6, 51953-04-9, 95121-06-5, NCGC00095622-01, DSSTox_CID_25983, DSSTox_RID_81271, DSSTox_GSID_45983, 146445-70-7, AG-670/31547063, Hypoxanthine-13C2,15N, CAS-68-94-0, 51953-23-2, purin-6(1H)-on, 3h-hypoxanthine, 6-hydroxypurin, 1vfn, 3nrz, InChI=1/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10, Hypoxanthine,(S), 1h-purin-6-ol, Hypoxanthine (VAN), NSC 129419, PubChem9283, 4-Hydroxy-1H-purine, Spectrum_001417, 1a9q, 7H-Purin-6-ol #, SpecPlus_000461, AC1Q6GPF, Spectrum2_001907, Spectrum3_001352, Spectrum4_001742, Spectrum5_000564, 3H-purin-6(7H)-one, ACMC-1AY8Z, ACMC-209o5e, bmse000094, D03HVE, Epitope ID:167471, AC1Q2AP6, 1,9-Dihydro-purin-6-one, Hypoxanthine, >=99.0%, ACMC-1C9T0, SCHEMBL25381, 7H-Purin-6-ol (9CI), BSPBio_003163, C5H3N4O, KBioGR_002184, KBioSS_001897, SPECTRUM310023, KSC353S0F, DivK1c_006557, SPBio_001874, AC1L1A12, GTPL4555, SCHEMBL1867923, DTXSID8045983, SCHEMBL17276814, BDBM82018, CTK0H0419, CTK0H0424, CTK1E4768, CTK1G8777, CTK2F3902, CTK3I5985, FDGQSTZJBFJUBT-UHFFFAOYSA-, KBio1_001501, KBio2_001897, KBio2_004465, KBio2_007033, KBio3_002383, CAS_790, NSC_790, MolPort-000-510-424, MolPort-000-799-859, MolPort-001-783-695, MolPort-002-640-011, MolPort-003-941-579, BCP22929, HY-N0091, NSC14665, Tox21_111511, ANW-35568, CCG-38478, CH0066, EBD130553, MFCD00005725, NSC-14665, PDSP1_000299, PDSP2_000297, s2424, SBB004203, STK804424, ZINC18153302, AKOS000267572, AKOS005221762, AKOS009159101, AKOS015888571, AKOS022168213, AKOS030544777, AKOS030619920, Tox21_111511_1, DB04076, MCULE-8326019285, PS-3167, RP20238, SDCCGMLS-0065594.P001, SDCCGMLS-0065594.P002, NCGC00095622-04, AC-10518, AJ-70362, AK-96690, AN-23780, CC-29453, CJ-15841, KB-73995, SC-06274, SY012477, 6H-Purin-6-one, 1,7-dihydro- (9CI), 6H-Purin-6-one, 3,7-dihydro- (9CI), AB0008347, DB-029904, KB-157893, KB-249883, LS-127207, TL8004832, CS-0007792, FT-0627170, ST50160486, 1,7-Dihydro-6H-purin-6-one (Hypoxanthine), Discontinued. See H998503 or H998504", EN300-37579, Hypoxanthine, Vetec(TM) reagent grade, 98%, Hypoxsanthine (1,7-Dihydro-6H-purin-6-one), 2899-EP2269996A1, 2899-EP2270008A1, 2899-EP2270505A1, 2899-EP2292617A1, 2899-EP2292630A1, 2899-EP2295503A1, 2899-EP2302382A2, 2899-EP2302383A2, 2899-EP2316974A1, 68H940, C00262, Z-4186, 30233-EP2277880A1, 30233-EP2284165A1, 30233-EP2287167A1, 30233-EP2292604A2, 30233-EP2292610A1, 30233-EP2292615A1, 30233-EP2295433A2, 30233-EP2305825A1, 30233-EP2311464A1, AB00674258-01, SR-05000002375, I01-1127, S14-2816, SR-05000002375-1, W-104648, F1386-0269, Hypoxanthine, powder, BioReagent, suitable for cell culture, 8C229956-6BE8-4F8D-91B7-0AD1EC294077, Didanosine impurity A,, European Pharmacopoeia (EP) Reference Standard, Didanosine Related Compound A, United States Pharmacopeia (USP) Reference Standard, InChI=1/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10), 184856-40-4, 184856-41-5, 25991-07-5, 25991-08-6, 25991-09-7, 39464-15-8, 39464-17-0, 480-99-9, 6535-89-3, Hypoxanthine, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production.